Quantum Simulation Technologies (QSimulate), a Boston, MA-based quantum simulation technology company focused on drug discovery and other industry research and development, raised $2.5M in funding.

Quantum Simulation Technologies（QSimulate）是一家总部位于马萨诸塞州波士顿的量子模拟技术公司，专注于药物发现和其他行业研发，筹集了250万美元的资金。

The round was led by 2xN. Other investors included UTokyo IPC and Kyoto iCAP.

该轮由2xN领导。其他投资者包括UTokyo IPC和Kyoto iCAP。

The company intends to use the funds to support its business centered on its quantum physics-based drug-discovery platform, QSP Life.

该公司打算利用这些资金支持其以量子物理为基础的药物发现平台QSP Life为中心的业务。

Led by CEO QSimulate is a leader in quantum simulation technology for drug discovery and other industry research and development. The company offers a range of products and services designed to leverage quantum mechanics to solve industrial-scale problems. The quantum physics-based drug-discovery platform, QSP Life, currently includes QUELO, QuValent, and QuantumFP, spanning small-molecule lead optimization to covalent inhibitor design, and to ultra-high-throughput molecular fingerprinting..

由首席执行官QSimulate领导，是药物发现和其他行业研究和开发的量子模拟技术领导者。该公司提供一系列旨在利用量子力学解决工业规模问题的产品和服务。基于量子物理学的药物发现平台QSP-Life目前包括QUELO，QuValent和QuantumFP，涵盖小分子铅优化到共价抑制剂设计和超高通量分子指纹图谱。。

In a multi-year partnership with Google Quantum AI, QSimulate has played a key role in the development of fault-tolerant quantum computing algorithms for chemical, material, and biomolecular problems. These contributions provide a roadmap for algorithm design in the quantum future supported by the existing QSimulate technologies.

在与Google Quantum AI的多年合作关系中，QSimulate在开发化学，材料和生物分子问题的容错量子计算算法方面发挥了关键作用。这些贡献为现有QSimulate技术支持的量子未来算法设计提供了路线图。

The ongoing collaborations with JSR Corporation and Google Quantum AI are a testament to its position in leveraging quantum mechanics for drug discovery and materials innovation, setting a new industry benchmark..

与JSR公司和Google Quantum AI的持续合作证明了其在利用量子力学进行药物发现和材料创新，建立新的行业基准方面的地位。。

FinSMEs

金融中小企业

29/11/2023

29/11/2023